Clearwater Analytics Holdings, Inc. (CWAN) presents a deeply negative liquidation posture as of March 31, 2026, consistent with its software-as-a-service profile. The MFFAIS-computed cash liquidation value of approximately negative $888 million reflects the structural asymmetry between a largely intangible asset base and face-value liabilities. Under a liquidation lens, total assets of $3.03 billion collapse materially: cash of $81.5 million recovers at par; accounts receivable of $169.6 million (gross $171.5M, net of $1.9M allowance) recovers at approximately 90-95%, yielding roughly $152-161 million; PP&E net of $30.5 million recovers at 50-70%, or $15-21 million; and operating lease ROU assets of $51.6 million carry nominal liquidation value given lease obligations remain at face value. The dominant balance-sheet features that destroy liquidation value are goodwill of $1.27 billion and finite-lived intangibles net of $660.7 million — together $1.93 billion — both assigned zero recovery under the liquidation lens. These arose primarily from the April 2025 acquisitions of Enfusion, Beacon, and Bistro, which also introduced the $817 million gross debt facility (2025 Credit Agreement, JPMorgan as agent) bearing SOFR-based interest; the carrying value net of issuance costs is $806.4 million. Total liabilities of $972.3 million stand at face value in liquidation, anchored by long-term debt of $806.4 million (current portion $8.0 million) and operating lease liabilities of $54.4 million ($14.2 million current, $40.2 million non-current). The deferred tax asset of $702.3 million is entirely acquisition-related and carries zero liquidation value. Quarter-over-quarter comparison against the prior 10-K (December 31, 2025) shows the balance sheet is broadly stable with no new material acquisitions in Q1 2026; the $17 million debt repayment in the quarter reduced gross debt from approximately $834 million to $817 million, a modest improvement in the liability stack. The pending go-private merger at $24.55 per share (Merger Agreement dated December 20, 2025, expected Q2 2026 close) creates a corporate action overlay but does not alter the liquidation analysis: the merger has not closed, all liabilities remain outstanding at face value, and the filing discloses $6.1 million in Q1 2026 transaction expenses. The share repurchase program remains suspended pending merger. Filing discloses $34.7 million in unrecorded unconditional purchase obligations (vendor commitments) which are not separately tagged in XBRL balance-sheet lines but are disclosed in the notes — these would constitute face-value liabilities in a wind-down. The deferred revenue liability (contract liabilities current) of $28.0 million is a performance obligation that extinguishes upon cessation of operations and would not need to be settled in cash in most wind-down scenarios, though counterparty refund claims introduce uncertainty.
▼ Community Notes